NCT00115154View on ClinicalTrials.gov

Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands

PHASE4CompletedINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

May 31, 2005

Study Completion Date

September 30, 2006

Conditions
Keratosis
Interventions
DRUG

Aldara (imiquimod) cream, 5%

Trial Locations (18)

10025

New York

14623

Rochester

23454

Virginia Beach

27834

Greenville

30263

Atlanta

Newnan

37922

Knoxville

47713

Evansville

53209

Milwaukee

60089

Buffalo Grove

75246

Dallas

77030

Houston

85710

Tucson

92083

Vista

97223

Portland

98801

Wenatchee

08075

Riverside Park

02903

Providence

Sponsors
All Listed Sponsors
lead

Graceway Pharmaceuticals, LLC

INDUSTRY